UNLABELLED: Despite an increasing use of high-resolution peripheral quantitative computed tomography (HR-pQCT) to evaluate bone morphology in vivo, there are reservations about its applicability in patients with osteoporosis and antiresorptive therapy. This study shows that HR-pQCT provides acceptable in vivo accuracy for bone volume fraction (BV/TV) in patients with osteoporosis and bisphosphonate (BP) treatment. INTRODUCTION: The primary aim was to analyze agreement of trabecular structure between HR-pQCT and gold standard microtomography (μCT) in patients with osteoporosis and long-term BP therapy. METHODS: In the BioAsset study, we analyzed cadaver radii and tibiae of 34 postmenopausal females (81.1 ± 7.1 years) with osteoporosis (no BP n = 22, 1-5 years BP n = 5, >5 years BP n = 7). Two HR-pQCT protocols (patient-mode and μCT-mode) were compared with gold standard μCT after image registration. Undecalcified histological sections were obtained to quantify nonmineralized bone matrix. Bland-Altman plots illustrated methodological agreement. Multiple regression analysis was used to test for variables associated with method agreement. RESULTS: In the radius and tibia, patient-mode HR-pQCT derived indices including bone volume fraction, trabecular number, and trabecular separation correlated well with gold standard μCT (R(2) = 0.78 - 0.88) except for trabecular thickness (R(2) = 0.11). Bland-Altman plots illustrated adequate agreement for bone volume fraction. Lower agreement of trabecular number and trabecular separation improved with decreasing structural impairment at the tibia only. Trabecular thickness was not appropriately assessed with HR-pQCT at both skeletal sites. Higher agreement for bone volume fraction was associated with increasing tissue mineral density in the tibia. CONCLUSIONS: HR-pQCT provides acceptable in vivo accuracy for BV/TV in patients with osteoporosis and BP treatment. Higher TMD was associated with higher BV/TV accuracy in vivo. Overall, methodological agreement got less accurate with increasing structural impairment in the tibia.
UNLABELLED: Despite an increasing use of high-resolution peripheral quantitative computed tomography (HR-pQCT) to evaluate bone morphology in vivo, there are reservations about its applicability in patients with osteoporosis and antiresorptive therapy. This study shows that HR-pQCT provides acceptable in vivo accuracy for bone volume fraction (BV/TV) in patients with osteoporosis and bisphosphonate (BP) treatment. INTRODUCTION: The primary aim was to analyze agreement of trabecular structure between HR-pQCT and gold standard microtomography (μCT) in patients with osteoporosis and long-term BP therapy. METHODS: In the BioAsset study, we analyzed cadaver radii and tibiae of 34 postmenopausal females (81.1 ± 7.1 years) with osteoporosis (no BP n = 22, 1-5 years BP n = 5, >5 years BP n = 7). Two HR-pQCT protocols (patient-mode and μCT-mode) were compared with gold standard μCT after image registration. Undecalcified histological sections were obtained to quantify nonmineralized bone matrix. Bland-Altman plots illustrated methodological agreement. Multiple regression analysis was used to test for variables associated with method agreement. RESULTS: In the radius and tibia, patient-mode HR-pQCT derived indices including bone volume fraction, trabecular number, and trabecular separation correlated well with gold standard μCT (R(2) = 0.78 - 0.88) except for trabecular thickness (R(2) = 0.11). Bland-Altman plots illustrated adequate agreement for bone volume fraction. Lower agreement of trabecular number and trabecular separation improved with decreasing structural impairment at the tibia only. Trabecular thickness was not appropriately assessed with HR-pQCT at both skeletal sites. Higher agreement for bone volume fraction was associated with increasing tissue mineral density in the tibia. CONCLUSIONS: HR-pQCT provides acceptable in vivo accuracy for BV/TV in patients with osteoporosis and BP treatment. Higher TMD was associated with higher BV/TV accuracy in vivo. Overall, methodological agreement got less accurate with increasing structural impairment in the tibia.
Authors: Matthias Krause; Stefan Breer; Michael Hahn; Wolfgang Rüther; Michael M Morlock; Michael Amling; Jozef Zustin Journal: Int Orthop Date: 2012-01-11 Impact factor: 3.075
Authors: Oleg Museyko; Fabian Eisa; Andreas Hess; Georg Schett; Willi A Kalender; Klaus Engelke Journal: Ann Biomed Eng Date: 2010-03-05 Impact factor: 3.934
Authors: A Bernhard; P Milovanovic; E A Zimmermann; M Hahn; D Djonic; M Krause; S Breer; K Püschel; M Djuric; M Amling; B Busse Journal: Osteoporos Int Date: 2013-04-30 Impact factor: 4.507
Authors: Matthias Priemel; Christoph von Domarus; Till Orla Klatte; Steffen Kessler; Julia Schlie; Simon Meier; Nils Proksch; Frederic Pastor; Clemens Netter; Thomas Streichert; Klaus Püschel; Michael Amling Journal: J Bone Miner Res Date: 2010-02 Impact factor: 6.741
Authors: Matthias Krause; Martin Rupprecht; Marcus Mumme; Klaus Püschel; Michael Amling; Florian Barvencik Journal: Clin Orthop Relat Res Date: 2013-07-27 Impact factor: 4.176
Authors: Babul Borah; Tom Dufresne; Joe Nurre; Roger Phipps; Paula Chmielewski; Leigh Wagner; Mark Lundy; Mary Bouxsein; Roger Zebaze; Ego Seeman Journal: J Bone Miner Res Date: 2010-01 Impact factor: 6.741
Authors: M Krause; J Keller; B Beil; I van Driel; J Zustin; F Barvencik; T Schinke; M Amling Journal: Osteoporos Int Date: 2014-11-13 Impact factor: 4.507
Authors: Y Lu; M Krause; N Bishop; K Sellenschloh; C-C Glüer; K Püschel; M Amling; M M Morlock; G Huber Journal: Osteoporos Int Date: 2014-08-19 Impact factor: 4.507
Authors: Ji Wang; Bin Zhou; Yizhong Hu; Zhendong Zhang; Y Eric Yu; Shashank Nawathe; Kyle K Nishiyama; Tony M Keaveny; Elizabeth Shane; X Edward Guo Journal: J Biomech Eng Date: 2019-01-31 Impact factor: 2.097
Authors: Elizabeth A Zimmermann; Eric Schaible; Bernd Gludovatz; Felix N Schmidt; Christoph Riedel; Matthias Krause; Eik Vettorazzi; Claire Acevedo; Michael Hahn; Klaus Püschel; Simon Tang; Michael Amling; Robert O Ritchie; Björn Busse Journal: Sci Rep Date: 2016-02-16 Impact factor: 4.379
Authors: M Peters; A Scharmga; A van Tubergen; J Arts; D Loeffen; R Weijers; B van Rietbergen; P Geusens; J P van den Bergh Journal: Calcif Tissue Int Date: 2017-03-28 Impact factor: 4.333